Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
(10) I.T.Gajger et al (2018) Stable gastric pentadecapeptide BPC 157 in honeybee (Apis mellifera) therapy, to control Nosema ceranae invasions in apiary conditions Journal of Veterinary Pharmacology and Therapeutics, 2018 Aug;41(4):614-621
Because the US Food and Drug Administration has not yet approved Cingal injections, they have not reached a broader market in the United States region
Heres what you need to know: Standard Dose: 250-500 mcg (0.25-0.5 mg) once daily via subcutaneous injection Clinical Range: Research protocols tested 250 mcg to 1 mg daily with no additional benefit above 1 mg Timing: Morning administration in completely fasted state for optimal lipolytic effect Administration: Subcutaneous injection into abdominal fat region Cycle Length: Typically 12-24 weeks based on metabolic goals and physician guidance Reconstitution: Mixed with bacteriostatic water
What that means for efficacy claims The volume of preclinical BPC-157 literature is sometimes cited as evidence that the compound "works." It is important to understand what preclinical evidence does and does not establish
US$ 28.62
US$ 24.87
US$ 23.81
US$ 22.12
US$ 27.32
US$ 27.01
